Atom Investors LP Olema Pharmaceuticals, Inc. Transaction History

Atom Investors LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$8.73 - $13.99 $522,106 - $836,685	-59,806 Reduced 63.41%	34,515 $373,000
Q1 2024 May 15, 2024	BUY	$10.95 - $16.62 $388,188 - $589,195	35,451 Added 60.22%	94,321 $1.07 Million
Q4 2023 Feb 14, 2024	BUY	$10.53 - $17.14 $619,901 - $1.01 Million	58,870 New	58,870 $825,000
Q1 2021 May 17, 2021	SELL	$27.81 - $53.64 $706,346 - $1.36 Million	-25,399 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$37.09 - $54.5 $942,048 - $1.38 Million	25,399 New	25,399 $1.22 Million

136

58.7M

141K

23.1K

Ticker OLMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,419,600
Market Cap $204M
Description
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

Stay updated on Atom Investors LP with notifications on news.